- Home
- KYMR vs MQ Comparison
KYMR vs MQ Comparison
Compare KYMR & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- MQ
- Stock Information
- Founded
- KYMR 2015
- MQ 2010
- Country
- KYMR United States
- MQ United States
- Employees
- KYMR N/A
- MQ N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- MQ Computer Software: Prepackaged Software
- Sector
- KYMR Health Care
- MQ Technology
- Exchange
- KYMR Nasdaq
- MQ Nasdaq
- Market Cap
- KYMR 3.1B
- MQ 2.9B
- IPO Year
- KYMR 2020
- MQ 2021
- Fundamental
- Price
- KYMR $43.51
- MQ $6.15
- Analyst Decision
- KYMR Strong Buy
- MQ Hold
- Analyst Count
- KYMR 15
- MQ 13
- Target Price
- KYMR $58.53
- MQ $5.98
- AVG Volume (30 Days)
- KYMR 722.6K
- MQ 4.0M
- Earning Date
- KYMR 10-30-2025
- MQ 11-03-2025
- Dividend Yield
- KYMR N/A
- MQ N/A
- EPS Growth
- KYMR N/A
- MQ N/A
- EPS
- KYMR N/A
- MQ N/A
- Revenue
- KYMR $44,711,000.00
- MQ $553,223,000.00
- Revenue This Year
- KYMR $58.45
- MQ $21.16
- Revenue Next Year
- KYMR N/A
- MQ $21.56
- P/E Ratio
- KYMR N/A
- MQ N/A
- Revenue Growth
- KYMR N/A
- MQ 17.47
- 52 Week Low
- KYMR $19.45
- MQ $3.37
- 52 Week High
- KYMR $53.27
- MQ $7.04
- Technical
- Relative Strength Index (RSI)
- KYMR 53.28
- MQ 51.47
- Support Level
- KYMR $39.84
- MQ $5.98
- Resistance Level
- KYMR $43.43
- MQ $6.46
- Average True Range (ATR)
- KYMR 2.03
- MQ 0.15
- MACD
- KYMR 0.15
- MQ -0.02
- Stochastic Oscillator
- KYMR 78.76
- MQ 48.49
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.